Cagey Sponsors, Defensive Vendors: Observations On How Transparency Breaks Down
By: Kalyan Obalampalli (KO), Founder and President of Clin.AI

Mistrust in clinical operations rarely starts with malicious intent. Instead, it begins when sponsors soften or hold back uncertain protocol details during the RFP stage to avoid confusion. This partial visibility forces CROs to protect themselves by building in defensive pricing, rigid assumptions, and frequent change orders. What looks like partner rigidity is often just a natural reaction to uncertainty.
True transparency doesn't require public disclosure; it simply means sharing operational likelihoods early. When partners are kept in the loop on potential changes, they can align resources, adjust timelines, and prepare regulatory pathways in advance. This article explores how replacing secrecy with early visibility transforms defensive vendors into proactive allies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.